Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

04.01.2021

2 AIDS
5 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Arch Dis Child
1 BMC Pediatr
1 BMJ
11 Clin Infect Dis
14 HIV Med
5 J Infect Dis
1 J Med Virol
3 J Virol
2 Lancet Infect Dis
1 PLoS Biol
22 PLoS One
3 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Vaccine



    AIDS

  1. BUDD A, Krentz HB, Rubin LH, Power C, et al
    Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
    AIDS. 2020;Publish Ahead of Print.
    >> Share

  2. NGONGO NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, et al
    Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC.
    AIDS. 2020;Publish Ahead of Print.
    >> Share


    AIDS Res Hum Retroviruses

  3. NGALAMIKA O, Munsaka S, Lidenge S, West J, et al
    Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-related, and Sociodemographic Predictors of Outcome.
    AIDS Res Hum Retroviruses. 2021 Jan 1. doi: 10.1089/AID.2020.0099.
    >> Share

  4. ZHAO R, Ding R, Zhang Q
    What are the risk factors for surgical site infection in HIV positive patients receiving open reduction and internal fixation of traumatic limb fractures? A retrospective cohort study.
    AIDS Res Hum Retroviruses. 2021 Jan 1. doi: 10.1089/AID.2020.0184.
    >> Share

  5. AL-KHOUJA A, Shieh EC, Fuchs EJ, Marzinke MA, et al
    Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: a First-in-Human Study.
    AIDS Res Hum Retroviruses. 2020 Dec 28. doi: 10.1089/AID.2020.0188.
    >> Share

  6. GUERRIERO KA, Murnane RD, Lewis TB, Brown B, et al
    Recrudescence of Natural Coccidioidomycosis during Combination Antiretroviral Therapy in a Pigtail Macaque Experimentally Infected with Simian Immunodeficiency Virus.
    AIDS Res Hum Retroviruses. 2020 Dec 23. doi: 10.1089/AID.2020.0228.
    >> Share

  7. MONTANO-CASTELLON I, Zeballos D, Gutierrez-Peredo G, Netto EM, et al
    "High prevalence of frailty and pre-frailty status in Brazilian patients living with HIV".
    AIDS Res Hum Retroviruses. 2020 Dec 22. doi: 10.1089/AID.2020.0113.
    >> Share


    Antimicrob Agents Chemother

  8. FERNANDEZ ML, Marson ME, Mastrantonio GE, Corti MA, et al
    BENZNIDAZOLE IN CEREBROSPINAL FLUID. A CASE SERIES OF CHAGAS DISEASE MENINGOENCEPHALITIS IN HIV POSITIVE PATIENTS.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.01922.
    >> Share


    Arch Dis Child

  9. CHAZIYA J, Freyne B, Lissauer S, Nielsen M, et al
    COVID-19 in Malawi: lessons in pandemic preparedness from a tertiary children's hospital.
    Arch Dis Child. 2020 Dec 23. pii: archdischild-2020-319980.
    >> Share


    BMC Pediatr

  10. TAMANDJOU TCHUEM C, Cotton MF, Nel E, Tedder R, et al
    Viral hepatitis B and C in HIV-exposed South African infants.
    BMC Pediatr. 2020;20:563.
    >> Share


    BMJ

  11. GOLD D
    Food banks and infant formula: formula is critical for mothers with HIV.
    BMJ. 2020;371:m4923.
    >> Share


    Clin Infect Dis

  12. RAJASINGHAM R, Boulware DR
    Cryptococcal Antigen Screening and Preemptive Treatment-How Can We Improve Survival?
    Clin Infect Dis. 2020;70:1691-1694.
    >> Share

  13. CASTILLO-MANCILLA JR
    Adherence to Antiretroviral Therapy and Pre-exposure Prophylaxis: TARGETing the Ideal Measure.
    Clin Infect Dis. 2020;70:2152-2154.
    >> Share

  14. WHITNEY BM, Srinivasan S, Tapia K, Muriuki EM, et al
    Influence of intramuscular depot-medroxyprogesterone acetate initiation on vaginal microbiota in the postpartum period.
    Clin Infect Dis. 2020 Dec 23. pii: 6044709. doi: 10.1093/cid/ciaa1876.
    >> Share

  15. GREENBERG L, Ryom L, Neesgaard B, Wandeler G, et al
    Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV.
    Clin Infect Dis. 2020 Dec 23. pii: 6044711. doi: 10.1093/cid/ciaa1878.
    >> Share

  16. CHRISTOPOULOS KA, Neilands TB, Koester KA, Sauceda JA, et al
    The HIV Index: Using a Patient-Reported Outcome on Engagement in HIV Care to Explain Sub-Optimal Retention in Care and Virologic Control.
    Clin Infect Dis. 2020 Dec 29. pii: 6054940. doi: 10.1093/cid/ciaa1892.
    >> Share

  17. TACK I, Dumicho A, Ohler L, Shigayeva A, et al
    Safety and effectiveness of an all-oral, bedaquiline-based, shorter treatment regimen for rifampicin-resistant tuberculosis in high HIV burden rural South Africa: a retrospective cohort analysis.
    Clin Infect Dis. 2020 Dec 29. pii: 6054965. doi: 10.1093/cid/ciaa1894.
    >> Share

  18. GRANICH R, Gupta S
    European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic.
    Clin Infect Dis. 2020;71:2917-2919.
    >> Share

  19. LEE JS, Humes EA, Hogan BC, Buchacz K, et al
    CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018.
    Clin Infect Dis. 2020 Dec 31. pii: 6056679. doi: 10.1093/cid/ciaa1904.
    >> Share

  20. CROWELL TA, Ritz J, Coombs RW, Zheng L, et al
    Novel Criteria for Diagnosing Acute and Early HIV Infection in a Multi-National Study of Early Antiretroviral Therapy Initiation.
    Clin Infect Dis. 2020 Dec 31. pii: 6056473. doi: 10.1093/cid/ciaa1893.
    >> Share

  21. DAS S, Allston A, Opoku J, Kharfen M, et al
    A spatial approach for Ending the HIV Epidemic for the United States - A DC Model.
    Clin Infect Dis. 2020 Dec 30. pii: 6055591. doi: 10.1093/cid/ciaa1761.
    >> Share

  22. BOEY L, Curinckx A, Roelants M, Derdelinckx I, et al
    Immunogenicity And Safety Of The Nine-Valent Human Papillomavirus Vaccine In Solid Organ Transplant Recipients And Hiv-Infected Adults.
    Clin Infect Dis. 2020 Dec 29. pii: 6054974. doi: 10.1093/cid/ciaa1897.
    >> Share


    HIV Med

  23. HU W, Jiao YM, Wang FS
    Snapshot of clinical studies on people living with HIV in China.
    HIV Med. 2020;21:681-682.
    >> Share

  24. YING RS, Le T, Cai WP, Li YR, et al
    Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017.
    HIV Med. 2020;21:729-738.
    >> Share

  25. ZHAO Y, Han MJ, Gan XM, Ma Y, et al
    Characteristics and viral suppression among people living with HIV from the National Free Antiretroviral Therapy Programme, 2019.
    HIV Med. 2020;21:701-707.
    >> Share

  26. QI TK, Chen J, Zhang RF, Liu L, et al
    A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality.
    HIV Med. 2020;21:739-746.
    >> Share

  27. ZHANG C, Hu W, Jin JH, Zhou MJ, et al
    The role of CD8 T cells in controlling HIV beyond the antigen-specific face.
    HIV Med. 2020;21:692-700.
    >> Share

  28. LIU A, Zhang L, Zhang X, Zhang HW, et al
    Delayed seroreversion of specifical antibody against HIV in HIV-exposed infants: A retrospective cohort study.
    HIV Med. 2020;21:718-721.
    >> Share

  29. LIN L, Li TS
    Multidisciplinary collaborative integrated management of increasingly prominent HIV complications in the post-cART era.
    HIV Med. 2020;21:683-691.
    >> Share

  30. LI JH, Ma J, Kang W, Wang CF, et al
    The histone deacetylase inhibitor chidamide induces intermittent viraemia in HIV-infected patients on suppressive antiretroviral therapy.
    HIV Med. 2020;21:747-757.
    >> Share

  31. JIANG TY, Hou JH, Su B, Zhang T, et al
    Demographic and clinical factors associated with immune reconstitution in HIV/HBV co-infected and HIV mono-infected patients: a retrospective cohort study.
    HIV Med. 2020;21:722-728.
    >> Share

  32. BAXTER JD, Dunn D, Tostevin A, Marvig RL, et al
    Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
    HIV Med. 2020 Dec 25. doi: 10.1111/hiv.13038.
    >> Share

  33. HOFFMANN C, Casado JL, Harter G, Vizcarra P, et al
    Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.
    HIV Med. 2020 Dec 27. doi: 10.1111/hiv.13037.
    >> Share

  34. LIU JY, Sun LQ, Hou YY, Wang LF, et al
    Barriers to early diagnosis and treatment of severely immunosuppressed patients with HIV-1 infection: A quantitative and qualitative study.
    HIV Med. 2020;21:708-717.
    >> Share

  35. GONZALEZ-SERNA A, Macias J, Palacios R, Gomez-Ayerbe C, et al
    Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain.
    HIV Med. 2020 Dec 26. doi: 10.1111/hiv.13039.
    >> Share

  36. REICHMUTH ML, Chaudron SE, Bachmann N, Nguyen H, et al
    Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.
    HIV Med. 2020 Dec 25. doi: 10.1111/hiv.13030.
    >> Share


    J Infect Dis

  37. SORTINO O, Dias J, Anderson M, Laidlaw E, et al
    Preserved MAIT cell numbers and function in idiopathic CD4 lymphocytopenia.
    J Infect Dis. 2020 Dec 25. pii: 6047591. doi: 10.1093.
    >> Share

  38. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.
    J Infect Dis. 2020 Dec 26. pii: 6053002. doi: 10.1093.
    >> Share

  39. KROEZE S, Rossouw TM, Steel HC, Wit FW, et al
    Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy.
    J Infect Dis. 2020 Dec 29. pii: 6054994. doi: 10.1093.
    >> Share

  40. JANKOWSKI CM, Wilson MP, MaWhinney S, Reusch J, et al
    Blunted muscle mitochondrial responses to exercise training in older adults with HIV.
    J Infect Dis. 2020 Dec 30. pii: 6055584. doi: 10.1093.
    >> Share

  41. RAWAT P, Brummel SS, Singh KK, Kim J, et al
    Genomics Links Inflammation with Neurocognitive Impairment in Children Living with Human Immunodeficiency Virus type-1.
    J Infect Dis. 2020 Dec 29. pii: 6054995. doi: 10.1093.
    >> Share


    J Med Virol

  42. DUBEY RC, Alam NB, Gaur R
    miR-150-mediated increase in glucose uptake in HIV-infected cells.
    J Med Virol. 2020 Dec 24. doi: 10.1002/jmv.26755.
    >> Share


    J Virol

  43. ZHANG Y, Murakoshi H, Chikata T, Akahoshi T, et al
    Effect of difference in consensus sequence between HIV-1 subtype A/E and subtype B viruses on elicitation of Gag-specific CD8(+) T cells and accumulation of HLA-associated escape mutations.
    J Virol. 2020 Dec 23. pii: JVI.02061-20. doi: 10.1128/JVI.02061.
    >> Share

  44. SANZ M, Madrid-Elena N, Serrano-Villar S, Vallejo A, et al
    Effect of the use of Galectin-9 and blockade of TIM-3 receptor in the latent cellular reservoir of HIV-1.
    J Virol. 2020 Dec 23. pii: JVI.02214-20. doi: 10.1128/JVI.02214.
    >> Share

  45. GAEBLER C, Falcinelli SD, Stoffel E, Read J, et al
    Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA.
    J Virol. 2020 Dec 23. pii: JVI.01986-20. doi: 10.1128/JVI.01986.
    >> Share


    Lancet Infect Dis

  46. HENGEL B, Causer L, Matthews S, Smith K, et al
    A decentralised point-of-care testing model to address inequities in the COVID-19 response.
    Lancet Infect Dis. 2020 Dec 23. pii: S1473-3099(20)30859.
    >> Share

  47. SAMER C, Lacombe K, Calmy A
    Cyber harassment of female scientists will not be the new norm.
    Lancet Infect Dis. 2020 Dec 23. pii: S1473-3099(20)30944.
    >> Share


    PLoS Biol

  48. BONS E, Leemann C, Metzner KJ, Regoes RR, et al
    Long-term experimental evolution of HIV-1 reveals effects of environment and mutational history.
    PLoS Biol. 2020;18:e3001010.
    >> Share


    PLoS One

  49. ABRAHIM SA, Tessema M, Defar A, Hussen A, et al
    Time to recovery and its predictors among adults hospitalized with COVID-19: A prospective cohort study in Ethiopia.
    PLoS One. 2020;15:e0244269.
    >> Share

  50. KASOZI S, Kirirabwa NS, Kimuli D, Luwaga H, et al
    Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    PLoS One. 2020;15:e0244451.
    >> Share

  51. CHEN Z, Dornelles A, Fang D, Wilson JR, et al
    Impacts on knowledge and testing on HIV in waves of Mozambique surveys with Bayes estimates.
    PLoS One. 2020;15:e0244563.
    >> Share

  52. PAWLOS A, Broncel M, Wlazlowska E, Jablonowska E, et al
    Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations.
    PLoS One. 2020;15:e0244675.
    >> Share

  53. MOHAMMED DY, Koumoulos LM, Martin E, Slim J, et al
    Annual and durable HIV retention in care and viral suppression among patients of Peter Ho Clinic, 2013-2017.
    PLoS One. 2020;15:e0244376.
    >> Share

  54. VU L, Burnett-Zieman B, Stoman L, Luu M, et al
    Effects of the implementation of the HIV Treat All guidelines on key ART treatment outcomes in Namibia.
    PLoS One. 2020;15:e0243749.
    >> Share

  55. AFAA TJ, Amegan-Aho KH, Dono MT, Odei E, et al
    Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa.
    PLoS One. 2020;15:e0239964.
    >> Share

  56. MELLGREN A, Eriksson LE, Reinius M, Marrone G, et al
    Longitudinal trends and determinants of patient-reported side effects on ART-a Swedish national registry study.
    PLoS One. 2020;15:e0242710.
    >> Share

  57. YANAGISAWA K, Wichukchinda N, Tsuchiya N, Yasunami M, et al
    Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand.
    PLoS One. 2020;15:e0242438.
    >> Share

  58. NEESGAARD B, Mocroft A, Zangerle R, Wit F, et al
    Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
    PLoS One. 2020;15:e0243625.
    >> Share

  59. KHLAIPHUENGSIN A, Chuaypen N, Sodsai P, Reantragoon R, et al
    Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.
    PLoS One. 2020;15:e0244112.
    >> Share

  60. BAM NE, Mabunda SA, Ntsaba J, Apalata T, et al
    The association between HIV tri-therapy with the development of Type-2 Diabetes Mellitus in a rural South African District: A case-control study.
    PLoS One. 2020;15:e0244067.
    >> Share

  61. HOLLOWAY IW, Krueger EA, Meyer IH, Lightfoot M, et al
    Longitudinal trends in PrEP familiarity, attitudes, use and discontinuation among a national probability sample of gay and bisexual men, 2016-2018.
    PLoS One. 2020;15:e0244448.
    >> Share

  62. WONDMIENEH A, Gedefaw G, Alemnew B, Getie A, et al
    Intestinal parasitic infections and associated factors among people living with HIV/AIDS in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0244887.
    >> Share

  63. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS.
    PLoS One. 2020;15:e0244800.
    >> Share

  64. KWEKA B, Lyimo E, Jeremiah K, Filteau S, et al
    Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
    PLoS One. 2020;15:e0244782.
    >> Share

  65. MUDIMU E, Peebles K, Mukandavire Z, Nightingale E, et al
    Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    PLoS One. 2020;15:e0244761.
    >> Share

  66. BARBE MF, Loomis R, Lepkowsky AM, Forman S, et al
    A longitudinal characterization of sex-specific somatosensory and spatial memory deficits in HIV Tg26 heterozygous mice.
    PLoS One. 2020;15:e0244725.
    >> Share

  67. PEARCE ME, Yu A, Alvarez M, Bartlett SR, et al
    Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008-2019.
    PLoS One. 2020;15:e0244575.
    >> Share

  68. SAZONOVA Y, Kulchynska R, Sereda Y, Azarskova M, et al
    HIV treatment cascade among people who inject drugs in Ukraine.
    PLoS One. 2020;15:e0244572.
    >> Share

  69. POTEAT T, Aqil A, Corbett D, Evans D, et al
    "I would really want to know that they had my back": Transgender women's perceptions of HIV cure-related research in the United States.
    PLoS One. 2020;15:e0244490.
    >> Share

  70. MACCARTHY S, Izenberg M, Barreras JL, Brooks RA, et al
    Rapid mixed-methods assessment of COVID-19 impact on Latinx sexual minority men and Latinx transgender women.
    PLoS One. 2020;15:e0244421.
    >> Share


    PLoS Pathog

  71. AKAHOSHI T, Gatanaga H, Kuse N, Chikata T, et al
    T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.
    PLoS Pathog. 2020;16:e1009177.
    >> Share

  72. UPADHYAY C, Feyznezhad R, Cao L, Chan KW, et al
    Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes.
    PLoS Pathog. 2020;16:e1009185.
    >> Share

  73. NOEL-ROMAS L, Perner M, Molatlhegi R, Farr Zuend C, et al
    Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition.
    PLoS Pathog. 2020;16:e1009097.
    >> Share


    Proc Natl Acad Sci U S A

  74. CACCURI F, D'Ursi P, Uggeri M, Bugatti A, et al
    Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
    Proc Natl Acad Sci U S A. 2021;118.
    >> Share


    Vaccine

  75. KOSKAN A, Klasko-Foster L, Stecher C, Rodriguez S, et al
    Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries.
    Vaccine. 2020 Dec 23. pii: S0264-410X(20)31609.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016